These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19007818)

  • 1. Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope.
    Cheong WS; Reiseger J; Turner SJ; Boyd R; Netter HJ
    Antiviral Res; 2009 Feb; 81(2):113-22. PubMed ID: 19007818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.
    Woo WP; Doan T; Herd KA; Netter HJ; Tindle RW
    J Virol; 2006 Apr; 80(8):3975-84. PubMed ID: 16571814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
    Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
    Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric calicivirus-like particles elicit protective anti-viral cytotoxic responses without adjuvant.
    Crisci E; Almanza H; Mena I; Córdoba L; Gómez-Casado E; Castón JR; Fraile L; Bárcena J; Montoya M
    Virology; 2009 May; 387(2):303-12. PubMed ID: 19327809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants.
    Kawano M; Morikawa K; Suda T; Ohno N; Matsushita S; Akatsuka T; Handa H; Matsui M
    Virology; 2014 Jan; 448():159-67. PubMed ID: 24314646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-loaded chimeric influenza virosomes for efficient in vivo induction of cytotoxic T cells.
    Amacker M; Engler O; Kammer AR; Vadrucci S; Oberholzer D; Cerny A; Zurbriggen R
    Int Immunol; 2005 Jun; 17(6):695-704. PubMed ID: 15843436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes.
    Liu WJ; Liu XS; Zhao KN; Leggatt GR; Frazer IH
    Virology; 2000 Aug; 273(2):374-82. PubMed ID: 10915608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimisation of secretion of recombinant HBsAg virus-like particles: Impact on the development of HIV-1/HBV bivalent vaccines.
    Michel M; Lone YC; Centlivre M; Roux P; Wain-Hobson S; Sala M
    Vaccine; 2007 Feb; 25(10):1901-11. PubMed ID: 17005303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of pre-existing immunity on the capacity of influenza virosomes to induce cytotoxic T lymphocyte activity.
    de Mare A; Bungener LB; Regts J; de Vries-Idema J; van der Zee AG; Wilschut J; Daemen T
    Vaccine; 2008 May; 26(19):2314-21. PubMed ID: 18400343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
    Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
    Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix.
    Cheong WS; Drummer HE; Netter HJ
    J Virol Methods; 2009 Jun; 158(1-2):35-40. PubMed ID: 19189849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granzyme A expression reveals distinct cytolytic CTL subsets following influenza A virus infection.
    Moffat JM; Gebhardt T; Doherty PC; Turner SJ; Mintern JD
    Eur J Immunol; 2009 May; 39(5):1203-10. PubMed ID: 19404988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of mucosal immune responses by chimeric influenza HA/SHIV virus-like particles.
    Yao Q
    Res Initiat Treat Action; 2003; 8(2):20-1. PubMed ID: 12845773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple copies of a tumor epitope in a recombinant hepatitis B surface antigen (HBsAg) vaccine enhance CTL responses, but not tumor protection.
    Haigh O; Guo H; Edgtton K; Mather M; Herd KA; Tindle RW
    Virology; 2007 Nov; 368(2):363-75. PubMed ID: 17689584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three different MHC class I molecules bind the same CTL epitope of the influenza virus in a primate species with limited MHC class I diversity.
    Evans DT; Knapp LA; Jing P; Piekarczyk MS; Hinshaw VS; Watkins DI
    J Immunol; 1999 Apr; 162(7):3970-7. PubMed ID: 10201917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.
    Dorn DC; Lawatscheck R; Zvirbliene A; Aleksaite E; Pecher G; Sasnauskas K; Ozel M; Raftery M; Schönrich G; Ulrich RG; Gedvilaite A
    Viral Immunol; 2008 Mar; 21(1):12-27. PubMed ID: 18355119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.